AirSculpt Technologies, Inc. (AIRS) Operating Margin
- Operating margin · 12 months: Value -8.35%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -8.35% | Operating income / revenue. Period ending 2026-06-30. $-12.59M ÷ $150.72M × 100 ≈ -8.35% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -12.59M USD | Operating Income (Loss) |
| Revenue | 150.72M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 83.74M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-12.59M | $150.72M | (m) | (m) | $83.74M | -8.35% |
| 2026-03-31 | $-11.77M | $151.84M | (m) | (m) | $82.99M | -7.75% |
| 2025-12-31 | $-11.56M | $151.82M | (m) | (m) | $82.18M | -7.61% |
| 2025-09-30 | $-14.68M | $157.55M | (m) | (m) | $87.32M | -9.32% |
| 2025-06-30 | $-8.65M | $165.11M | (m) | (m) | $93.29M | -5.24% |
| 2025-03-31 | $-14.42M | $172.10M | (m) | (m) | $104.89M | -8.38% |
| 2024-12-31 | $-1.82M | $180.35M | (m) | (m) | $98.88M | -1.01% |
| 2024-09-30 | $3.72M | $188.78M | (m) | (m) | $101.10M | 1.97% |
| 2024-06-30 | $8.39M | $193.03M | (m) | (m) | $100.64M | 4.35% |
| 2024-03-31 | $18.73M | $197.72M | (m) | (m) | $94.25M | 9.47% |
| 2023-12-31 | $9.48M | $195.92M | (m) | (m) | $102.38M | 4.84% |
| 2023-09-30 | $2.12M | $189.01M | (m) | (m) | $104.65M | 1.12% |
| 2023-06-30 | $-213.00K | $181.11M | (m) | (m) | $103.02M | -0.12% |
| 2023-03-31 | $-1.61M | $175.06M | (m) | (m) | $101.13M | -0.92% |
| 2022-12-31 | $-4.54M | $168.79M | (m) | (m) | $101.42M | -2.69% |
| 2022-09-30 | $-10.84M | $165.65M | (m) | (m) | $108.38M | -6.54% |
| 2022-06-30 | $155.00K | $161.41M | (m) | (m) | $96.92M | 0.10% |
| 2022-03-31 | $7.39M | $146.72M | (m) | (m) | $81.24M | 5.04% |
| 2021-12-31 | $15.77M | $133.31M | (m) | (m) | $65.73M | 11.83% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $10.03M | $62.77M | (m) | (m) | $23.62M | 15.98% |
| 2019-12-31 | $663.00K | $41.24M | (m) | (m) | $20.13M | 1.61% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |